Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May-Jun;15(3):1039-1045.
doi: 10.1016/j.dsx.2021.04.026. Epub 2021 May 18.

Cerebral venous thrombosis in COVID-19

Affiliations
Review

Cerebral venous thrombosis in COVID-19

Ritwik Ghosh et al. Diabetes Metab Syndr. 2021 May-Jun.

Abstract

Background and aims: Initially, novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) was considered primarily a respiratory pathogen. However, with time it has behaved as a virus with the potential to cause multi-system involvement, including neurological manifestations. Cerebral venous sinus thrombosis (CVT) has increasingly been reported in association with coronavirus infectious disease of 2019 (COVID-19). Here, we have shed light upon CVT and its possible mechanisms in the backdrop of the ongoing COVID-19 pandemic.

Methods: In this review, data were collected from PubMed, EMBASE and Web of Science, until March 30, 2021, using pre-specified searching strategies. The search strategy consisted of a variation of keywords of relevant medical subject headings and keywords, including "COVID-19", "SARS-CoV-2", "coronavirus", and "cerebral venous sinus thrombosis".

Results: COVID-19 has a causal association with a plethora of neurological, neuropsychiatric and psychological effects. CVT has gained particular importance in this regard. The known hypercoagulable state in SARS-CoV-2 infection is thought to be the main mechanism in COVID-19 related CVT. Other plausible mechanisms may include vascular endothelial dysfunction and altered flow dynamics.

Conclusions: Although there are no specific clinical characteristics, insidious or acute onset headache, seizures, stroke-like, or encephalopathy symptoms in a patient with, or who has suffered COVID-19, should prompt the attending physician to investigate for CVT. The treatment of COVID-19 associated CVT does not differ radically from the therapy of CVT without the infection, i.e. urgent initiation of parenteral unfractionated heparin or low molecular weight heparin followed by conventional or mostly newer oral anticoagulants.

Keywords: COVID-19; Cerebral venous thrombosis; Neuro-COVID; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Possible mechanisms through which SARS-CoV-2 can lead to cerebral venous thrombosis.

References

    1. Roy D., Ghosh R., Dubey S., Dubey M.J., Benito-León J., Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9–24. doi: 10.1017/cjn.2020.173. - DOI - PMC - PubMed
    1. Ghosh R., Dubey S., Kanti Ray B., Chatterjee S., Benito-León J. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy. Can J Neurol Sci. 2020;47(6):849–851. doi: 10.1017/cjn.2020.117. - DOI - PMC - PubMed
    1. Ghosh R., Lahiri D., Dubey S., Ray B.K., Benito-León J. Hallucinatory palinopsia in COVID-19 induced posterior reversible encephalopathy syndrome. J Neuroophthalmol. 2020;40(4):523–526. doi: 10.1097/WNO.0000000000001135. - DOI - PubMed
    1. Ghosh R., Roy D., Sengupta S., Benito-León J. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19. J Neurovirol. 2020 Dec;26(6):964–966. doi: 10.1007/s13365-020-00908-2. - DOI - PMC - PubMed
    1. Ghosh R., Dubey S., Finsterer J., Chatterjee S., Ray B.K. SARS-CoV-2-Associated acute hemorrhagic, necrotizing encephalitis (ahne) presenting with cognitive impairment in a 44-year-old woman without comorbidities: a case report. Am J Case Rep. 2020;21:e925641. doi: 10.12659/AJCR.925641. - DOI - PMC - PubMed